http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2414206-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5a6907c0df7c11e72803b375909e45fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9494c30f8f6cb9e15dc21e0d6895855
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22
filingDate 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fba409fd58742cc3f13f55ce548eba1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3f0bff1c920c3eaf780643495ef04de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2395b85fd481b1e436fe87495a82cb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffef836579578b50a5fb4d436cdaa63
publicationDate 2011-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2414206-C1
titleOfInvention Method of reducing spontaneous erythrocyte aggregation in case of arterial hypertension with abdominal obesity and dyslipidemia
abstract FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to hematology and cardiology. Method includes administration to patients of complex from hypocaloric diet, dosed static and dynamic physical activity, including morning hygienic gymnastics, preventive medical gymnastics, divided physical exercise throughout the day, daily swimming for not less than 30 min per day in the middle of the day, intake of lisinopril in dose 10 mg 1 time per day in the morning and simvastatin 20 mg 1 time per day in the morning during 2 months. Combined application of all components makes it possible to reduce SEA in patients with AH with AO and D, reducing it to the level close to such for healthy people, during 2 months of treatment. ^ EFFECT: reduction of spontaneous erythrocyte aggregation (SEA) in case of arterial hypertension (AH) with abdominal obesity (AO) and dyslipidemia (D). ^ 2 ex
priorityDate 2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362119
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595

Total number of triples: 23.